In vitro modulation of macrophage functions by 1,1-dimethylhydrazine (UDMH): Possible mechanism for UDMH-induced immuno-enhancement.

[1]  Olsen Rg,et al.  Enhancement of murine mixed lymphocyte response by 1,1-dimethylhydrazine: characterization and possible mechanism. , 1988 .

[2]  J. Ninnemann.  Prostaglandins and immunity. , 1984, Immunology today.

[3]  G. Panayi,et al.  Prostaglandin regulation of B-lymphocyte function. , 1984, Immunology today.

[4]  C. Janeway,et al.  Quantitative variation in la antigen expression plays a central role in immune regulation. , 1984, Immunology today.

[5]  R. Maca.  The effects of prostaglandins on the proliferation of cultured human T lymphocytes. , 1983, Immunopharmacology.

[6]  P. J. Durant,et al.  Lupus erythematosus-like disease due to hydrazine. , 1983, The American journal of medicine.

[7]  B. Zwilling,et al.  Production of arachidonic acid metabolites by operationally defined macrophage subsets. , 1983, Prostaglandins.

[8]  M. Tarr,et al.  In vivo and in vitro effects of 1,1-dimethylhydrazine on selected immune functions. , 1982, Immunopharmacology.

[9]  E. Mihich,et al.  Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells. , 1982, International journal of immunopharmacology.

[10]  M. J. Ehrke,et al.  Modulation of the development of cell-mediated immunity: possible role of the products of the cyclo-oxygenase and the lipoxygenase pathways of arachidonic acid metabolism. , 1982, International journal of immunopharmacology.

[11]  E. Kraut,et al.  The effect of oxidant injury on the lymphocyte membrane and functions. , 1981, The Journal of laboratory and clinical medicine.

[12]  R. Fertel,et al.  Formation of antibodies to prostaglandins in the yolk of chicken eggs. , 1981, Biochemical and biophysical research communications.

[13]  E. Benjamini,et al.  Effects of prostaglandin synthesis inhibition on the immune response. , 1981, Immunopharmacology.

[14]  F. Dost,et al.  Metabolic fate of hydrazine. , 1981, Journal of toxicology and environmental health.

[15]  B. Tóth,et al.  Carcinogenesis by a single dose of N-methyl-N-formylhydrazine. , 1980, Journal of toxicology and environmental health.

[16]  E. Razin,et al.  The role of prostaglandins in the development of macrophages from bone marrow cells. , 1980, Journal of the Reticuloendothelial Society.

[17]  J. Oppenheim,et al.  Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. , 1980, Journal of immunology.

[18]  S. Wahl,et al.  ROLE OF CYTOKINE-AND ENDOTOXIN–INDUCED MONOKINES IN LYMPHOCYTE PROLIFERATION, DIFFERENTIATION, AND IMMUNOGLOBULIN PRODUCTION , 1980 .

[19]  E. Unanue.  T CELL-MACROPHAGE INTERACTION IN INFECTION TO THE INTRACELLULAR PATHOGEN LISTERIA MONOCYTOGENES , 1980 .

[20]  J. Kay,et al.  Separation of functionally distinct subpopulations of Corynebacterium parvum-activated macrophages with predominantly stimulatory or suppressive effect on the cell-mediated cytotoxic T cell response. , 1979, Cellular immunology.

[21]  K. Van Dyke,et al.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states , 1978, Infection and immunity.

[22]  K. Resch,et al.  The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. , 1978, Journal of immunology.

[23]  R. Messner,et al.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell , 1977, The Journal of experimental medicine.

[24]  L. Pelus,et al.  Prostaglandins and the immune response. , 1977, Life sciences.

[25]  W. Regelson,et al.  Clinical trial of hydrazine sulfate in solid tumors. , 1976, Cancer treatment reports.

[26]  H. Kirchner,et al.  Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum. , 1975, Journal of immunology.

[27]  J. Macewen.  The Effects of 6-Month Chronic Low Level Inhalation Exposures to Hydrazine on Animals , 1974 .

[28]  F. DeRubertis,et al.  Release of prostaglandin by mitogen- and antigen-stimulated leukocytes in culture. , 1974, The Journal of clinical investigation.

[29]  H. Perry.  Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. , 1973, The American journal of medicine.

[30]  M. Scott.  Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity. , 1972, Cellular immunology.

[31]  K. Back,et al.  Absorption, distribution, and excretion of 1, 1-dimethylhydrazine (UDMH). , 1963, Toxicology and applied pharmacology.

[32]  E. Freis,et al.  The Hemodynamic Effects of Hypotensive Drugs in Man: IV. 1‐Hydrazinophthalazine , 1953, Circulation.